Background
Ovarian cancer is the most frequently diagnosed tumor and lethal gynecological malignancy in the globe. Owing to the non-specific symptoms associated with the disease, most of the ovarian cancer cases are presented with advanced stage disease and lead to high mortality rates [
1,
2]. Despite modest improvements in response rates, progression-free and median survival rates using adjuvant platinum and taxane chemotherapy following cytoreductive surgery, the overall survival rates for patients with advanced ovarian cancer remain disappointing [
3,
4]. This is thought to be due to a small subset of cells within the tumor, namely ovarian cancer stem-like cells (OCSLCs) that are resistant to conventional chemotherapy treatments [
5]. Current chemotherapy agents aimed on the rapidly dividing cells; however, OCSLCs are not effectively killed by these compounds duo to their slow-division [
6,
7]. Therefore, finding and developing a candidate agent that target OCSLCs for the treatment of human ovarian cancer remains important and has clinical implications.
Jackson et al. reported that spheres derived from SKOV3 cells have relatively strong growth potential both in vivo and in vitro compared with the monolayer, indicating that the spheres have the characteristics of OCSLCs [
8]. We have recently used stem cell conditioned culture system to obtain the second generation spheres derived from SKOV3 cells, followed by demonstrated the spheres have the characteristics of cancer stem cells (CSCs), considering them as SKOV3-derived OCSLCs [
9,
10]. Nowadays, the tumor infiltrating inflammatory cells are mainly considered as tumor associated macrophages (TAMs), which play an important role in tumorigenesis, cancer invasion and metastasis [
11,
12]. Recent studies have shown that the interaction of TAM and OCSLCs is involved in the occurrence, recurrence and multidrug resistance of ovarian cancers [
13,
14]. Our previous study showed that THP-1 macrophages co-cultured with SKOV3-derived OCSLCs contain the characteristics of TAMs [
15]. In this study, we thus used the co-culture of THP-1 macrophages and SKOV3-derived OCSLCs to establish an experimental system for interaction between TAM and OCSLCs.
Importantly, several studies have confirmed that signal transducer and activator of transcription 3 (STAT3) activation is involved in the interaction between CSCs and their microenvironment, which effectively promoted the characterization of CSCs [
16‐
18]. Furthermore, interleukin-8 (IL-8) triggers the activation of STAT3 signaling, which is associated with inflammation, production of reactive oxygen species, ovarian cancer tumorigenesis and multidrug resistance [
19,
20]. Mohamed et al reported that IL-8 secreted from macrophages of patients with inflammatory breast cancer is involved in enhancing migration, invasion and metastasis [
21]. Tsuyada et al reported that breast cancer cells secrete multiple cytokines and activate STAT3 induced from breast cancer associated fibroblasts [
22]. The study conducted in our laboratory showed that OCSLCs co-cultured with macrophages induced SKOV3 cell stemness via IL-8/STAT3 signaling [
15]. These data indicated that blocking IL-8/STAT3 signaling of TAMs can evidently hinder the communication between the tumor and the host stromal cells, suggesting it as a novel therapeutic target for cancer stem cells that mediate the evolution of ovarian cancer and other malignant diseases.
Several comparative studies reported that the levels of soy products and isoflavones were negatively correlated with the incidence of various cancers, including ovarian cancer [
23‐
25]. In vitro and in vivo analyses showed that genistein (GEN), an isoflavone compound that is derived from legumes and dentate plants, inhibited oncogenicities in several cancer cells, including cancer stem cell like cells (CSLCs) [
26]. GEN has also been reported to display chemopreventive activity in inflammation-associated cancers [
27]. Accordingly, we aimed to assess whether and how GEN inhibits the stemness of ovarian cancer cells induced by co-culturing of THP-1 macrophages and OCSLCs.
Methods
Cell line and co-culture
Human ovarian cancer SKOV3 and OVCAR-3 cells and human monocyte THP-1 cells were obtained from the cell bank of Chinese Academy of Sciences (Shanghai, China).
SKOV3 and OVCAR-3 cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) with high glucose (Gibco, Grand Island, NY, USA), containing 10% fetal bovine serum (FBS), 100 IU/ml penicillin, and 100 μg/ml streptomycin, and then were incubated at 37 °C in an atmosphere with 5% CO
2. The second generation spheres of SKOV3 cells were obtained using sphere-forming assay, and then were considered as OCSLCs [
15].
THP-1 cells were cultured in RPMI-1640 medium (Gibco, USA) supplemented with 10% FBS (Gibco, USA), 100 IU/ml penicillin G, and 100 μg/ml streptomycin, and then were incubated in a humidified atmosphere of 5% CO
2 at 37 °C. THP-1 macrophages were induced by phorbol-12-myristate-13-acetate (PMA; final concentration: 100 ng/ml) for 24 h. Activated THP-1 macrophages were obtained as previously described [
15]. In brief, the THP-1 macrophages (2 × 10
6) were plated in the lower chamber and cultured for 12 h. Then the SKOV3- and OVCAR-3-derived OCSLCs (2 × 10
6) were seeded in the upper chamber and co-cultured for 24 h in transwell system (BD Biosciences, San Jose, CA, USA). After that, the THP-1 macrophages activated OCSLCs in the lower chamber and the supernatant of co-culture (Co-CM) were collected.
SKOV3 and OVCAR-3 cells (2 × 10
3) were suspended in serum-free DMEM/F12 mixture containing 100 IU/ml penicillin, 100 μg/ml streptomycin, 20 ng/ml hrEGF, 20 ng/ml hbFGF, 0.2% B27, 0.4% BSA, and 4 μg/ml insulin (cancer stem cell conditioned medium, CSC-CM) as well as Co-CM (
v/v: 1:1). The cells were then seeded in an ultra low attachment 6-well plate (Corning Inc., Coring, NY, USA). The total number of tumor spheres was counted after culturing for 8 days. The efficiency of sphere formation was calculated as previously described [
15]. Three independent experiments were performed.
DMEM medium containing 0.7% agarose was added into a 6-well plate. Then, 104 SKOV3 and OVACR-3 cells were seeded per well in CSC-CM as well as Co-CM (v/v: 1:1) containing 0.4% agarose (top layer), and incubated for 3 weeks. Colony count was carried out by using an inverted microscope (Olympus IX53, Japan). Three independent experiments were performed.
Depletion of IL-8 or addition of IL-8
Co-CM was collected, and was incubated with IL-8 neutralizing antibody (50 nM) (PeproTechInc, USA) for overnight at 4 °C. Then the medium was centrifuged at 12,000 g for 10 min, and the supernatants were collected for use as conditioned medium for IL-8 immunodepletion. Collected Co-CM was mixed with sterile 10 ng/ml of recombinant human IL-8 (R&D Systems, USA), and this was considered as the conditioned medium for adding IL-8.
Adenovirus infection
THP-1 macrophages (1 × 105) were seeded into 6-well culture plates (Corning Inc.) and incubated overnight until they reach 50% confluence, and infected with adenoviral particles loaded with pHBad-MCMV-EGFP-STAT3, pHBad-MCMV-EGFP, pHBad-U6-GFP-shSTAT3, and pHBad-U6-GFP plasmids (Hanbio Biotechnology Co. Ltd., Shanghai, China), respectively. The cells were cultured with Opti-MEM containing 50.0 μL adenoviral particles (Han Heng Biotech Corp) using Enhanced Infection Solution (Jikai gene Co., Ltd., Shanghai, China) for 2 h, and after which, the medium was replaced with DMEM containing 10% FBS. Infection efficiency was calculated by counting GFP-positive cells and live cells using the same high power field under a fluorescent microscope (Olympus IX53, Japan).
Enzyme-linked immunosorbent assay
Co-CM was collected from SKOV3- or OVCAR-3-derived OCSLC/THP-1 macrophage co-cultures, centrifuged at 1000 g for 5 min to obtain the supernatants, and then assessed for IL-10, IL-12, and IL-8 levels by ELISA with specific kits (Neobioscience, Shenzhen, Guangdong, China) according to the manufacturer’s instructions. Absorbance was immediately read at 450 nm on a microplate reader (BioTek, Winooski, Vermont, USA).
GEN treatment in vitro
To examine the effects of GEN on co-cultures, THP-1 macrophages co-cultured with SKOV3- or OVCAR-3-derived OCSLCs were treated with or without different concentrations of GEN (10, 20, and 40 μmol/L) for 24 h. For determining the induced effects of GEN combined with depletion or addition of Co-CM on macrophage polarization and SKOV3 cell stemness, the THP-1 macrophages and SKOV3 cells were treated with or without the conditioned medium from Co-CM depleted IL-8 by neutralizing antibody or added recombinant human IL-8 in the presence or absence of GEN (10 μM). To evaluate the linkage between STAT3 activation in THP-1 macrophages and GEN treatment in co-cultured THP-1 macrophages with SKOV3-derived OCSLCs, the co-culture of THP-1 macrophages expressing STAT3 or STAT3 shRNA or both with SKOV3-derived OCSLCs were treated with or without GEN (10 μM).
Western blot analysis
The cells were harvested and lysed using ice-cold RIPA lysis buffer (Beyotime Biotechnology, CN). Bradford assay (Bio-Rad Laboratories, Hercules, USA) was used to determine the protein concentration. Equal amounts of protein (40 μg) were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and then transferred onto a polyvinylidenedifluoride membrane (Millipore, Billerica, USA). The membranes were then blocked with TBST supplemented with 5% BSA for 2 h at room temperature, and incubated with primary antibodies against CD133, CD44, CD163 and STAT3 (Abcam, Burlingame, USA, dilution of 1:2000), Nanog and Oct4 (Cell Signaling Technology; Danvers, MA, USA), p-STAT3 (Tyr 705) and β-actin (Santa Cruz, USA, dilution of 1:2000) for overnight at 4 °C. The membranes were incubated with a horseradish peroxidase-conjugated goat anti-mouse IgG antibody or goat anti-rabbit IgG antibody (Beyotime Institute of Biotechnology, Shanghai, China) for 1 h. The protein bands were detected using enhanced chemiluminescence kit (Amersham Biosciences, Piscataway, USA).
In vivo tumorigenicity experiments
Female BALB/c-nude mice (4–5 weeks of age, body weight 12–14 g) were purchased from Nanjing Institute of Biomedical Research in Nanjing University. The experimental procedure was performed in accordance with the standard protocols and approved by the Ethics Committee of Hunan Normal University (No. 2015–055) and the Committee of Experimental Animal Feeding and Management (ID: 201607119). Mice were acclimated to their new environment for 1 week prior to undergoing the experiment.
To determine that effects of interaction between SKOV3-derived OCSLCs and THP-1 macrophages on the growth of tumors in nude mice in vivo, the mice were injected with SKOV3-derived OCSLCs (1 × 105 cells) in the left flank, and co-injected OCSLCs (1 × 105 cells)/THP-1 macrophages (2 × 105 cells) in the right flank, respectively.
For GEN therapeutic experiments, SKOV3-derived OCSLCs (1 × 105) and THP-1 macrophages (2 × 105) were mixed with matrigel (1:1), and then 100 μL mixture was injected subcutaneously into each Balb/c-nu mouse. After the xenograft volume achieved about 100mm3, the mice were randomly divided into 4 groups, with 4 mice in each group. Group 1 mice were given olive oil by gavage and was considered as control group; Group 2 mice were orally given Genistein dissolved in olive oil (50 mg/kg), once on alternate days, for a total of 10 times; Group 3 mice were intratumorally injected with 20 μL per mouse of adenovirus loaded with pHBad-U6-GFP-shSTAT3 (Hanbio Biotechnology Co. Ltd), once a week, for a total of 3 times; and Group 4 mice were orally given Genistein (50 mg/kg) plus injected the adenovirus expressing STAT3 shRNA. Then, the longest (L) and shortest (W) diameters of the subcutaneous xenografts were measured with a Vernier caliper for volume assessment, according to the following formula: V (transplanted tumor volume, mm3) = L × (W)2 × 0.5. At the end of the experiment, the mice were euthanized and xenografts were weighed after extraction. Xenograft specimens were fixed in 10% neutral formalin. Tissue sections were submitted to H&E staining, and the histopathological morphology was evaluated by optical microscopy.
Statistical analysis
Data were analyzed using SPSS 20.0 for Windows (SPSS Inc., Chicago, USA). All the experiments were repeated three times and the data were presented as means±SD. Comparisons between the groups for statistical significance were conducted using a two-tailed Student’s t-test. The differences between multiple groups were analyzed by one-way analysis of variance. First, the homogeneity of variance was determined, and all the pairwise comparisons between the groups were analyzed using least significant difference (LSD) method. Tukey’s test was performed in the event of incomplete variance of both the control and the experimental groups. Significance was determined as p < 0.05.
Discussion
The present study showed that GEN reduced the levels of IL-8 in Co-CM from OCSLCs co-cultured with THP-1 macrophages and inhibited the expression of CD163 and p-STAT3 in THP-1 macrophages, indicating that GEN can reverse M2 polarization of THP-1 macrophages. Moreover, GEN suppressed the sphere and colony formation capabilities and significantly decreased the protein expressions of CD44 and CD133 in ovarian cancer cells induced by Co-CM. These results proved that GEN disrupts the interaction of OCSLCs and TAM, inhibits stemness of ovarian cancer cells induced by co-culture. Therefore, the present study strongly supported the notion that interaction of OCSLCs and TAM contributed to carcinogenicity and progression in human ovarian cancer through elevated IL-8 levels in the microenvironment and activated oncogenic transcription factor STAT3 in THP-1 macrophages co-cultured OCSLCs. This regulation may likely involve the effects of GEN on the prevention and therapy of inflammation-associated cancers, including ovarian cancer.
In addition, activation of IL-8 signal transduction provided tumor cells with chemotherapeutic resistance [
28,
29]. IL-8 activates several intracellular signaling pathways in downstream of G-protein-coupled receptor (GPCR) such as CXCR1 and CXCR2 on two kinds of cell surface. The expression of IL-8 and/or its receptors in tumor cells, endothelial cells, infiltrating neutrophils and TAMs has been significantly increased [
30,
31]. Nonetheless, the genetic cells were still not decided, and we herein revealed increased IL-8 secretion in Co-CM and similarly its IL-8 levels in SKOV3-derived OCSLCs with THP-1 macrophages co-injected xenografts. In addition, we also demonstrated that alterations of IL-8 concentrations in Co-CM significantly affected M2 polarization of THP-1 macrophage and stemness of SKOV3 cells. Therefore, inhibition of IL-8 signal transduction may be an important therapeutic intervention for targeting tumor microenvironment.
Studies have shown that IL-8 triggers activation of STAT3 signal transduction, which was associated with inflammation, production of reactive oxygen species, tumorigenicity and drug resistance of ovarian epithelial cancer [
32‐
34]. In the present study, we found that knockdown or overexpression of STAT3 in THP-1 macrophages in co-culture system significantly changed the functions that promoted M2 polarization of THP-1 macrophages and stemness of SKOV3 cells induced by co-culture. Furthermore, alteration of STAT3 gene in THP-1 macrophages could change the levels of IL-8 of Co-CM. Given that the STAT3 activation of either CSLCs or TAMs was regulated by varied factors, investigation of STAT3 activation in response to cytokines, chemotactic factors, and other signaling molecules stimulation in tumor microenvironment is conceivable.
Study by Green et al. showed that GEN analogs N-t-boc-Daidzein is used as a new compound for inducing ovarian CSC apoptosis [
35]. Our previous studies confirmed that a novel synthetic GEN analogue 7-difluoromethoxyl-5,4′-di-n-octylgenistein (DFOG) effectively inhibited the self-renewal ability of SKOV3-derived OCSLCs [
9,
36]. In the current study, we initially provided the evidence that GEN effectively inhibited M2 polarization of THP-1 macrophages and stemness of SKOV3 cells induced by co-culture. Mechanistically, inhibition of M2 polarization of THP-1 macrophages and stemness of SKOV3 cells might be involved in the modulation of secretion of IL-8 in Co-CM and STAT3 activation in THP-1 macrophages in SKOV3-derived OCSLCs and THP-1 macrophage co-culture system. Since IL-8 triggers the activation of STAT3, it is involved in the interaction of tumor microenvironment and CSCs, and can effectively promote the characteristics of CSCs [
37,
38]. It is likely that GEN may exert chemoprevention efficacy in several inflammation-associated cancers, not only in ovarian cancer.
Our recent study showed that co-culture of OCSLCs with macrophages induced ovarian cancer cells stemness via IL-8/STAT3 signaling in vitro [
15]. Notably, the results observed in the present study proved that the growth velocity of xenografts from co-injection of SKOV3-derived OCSLCs/THP-1 macrophages in nude mice was faster than that of the injection of SKOV3-derived OCSLC alone in vivo
. More importantly, we demonstrated that co-administration of GEN by gavage and Ad-STAT3 shRNA by intratumoral injection significantly reduced the growth of xenografts by co-injection with OCSLCs/THP-1 macrophages. Therefore, combination of GEN and other STAT3 inhibitors should be a promising and useful therapeutic schedule against inflammation-associated ovarian cancers.
Increasing evidence has revealed the major contribution of TAM in the regulation of stemness of CSLCs through different networks of cytokines, chemokines and growth factors. In these processes, TAM interact with and promote stemness of CSLCs via releasing of milk-fat globule-epidermal growth factor–VIII (MFG-E8) and IL-6 through coordinated activation of the STAT3 and sonic hedgehog pathways [
39]. Interestingly, CSLCs are the major subpopulation driving the production of MFG-E8 and IL-6 from macrophages, suggesting that mediators specifically regulated by CSLCs confer macrophages with the ability to promote the generation of tumorigenic factors such as MFG-E8 and IL-6. In return, expansion of CSLC pool lead to stemness maintenance, and immune modulation within tumor microenvironments [
40,
41]. In the previous and current studies, we showed the interplay between OCSLCs and TAM accelerates tumor progression through IL-8/STAT3 autocrine positive-feedback mechanisms [
15]. Our data provide insight to the molecular interplay between CSLCs and TAMs for inflammation-related human ovarian cancers.